- Home
- SNN
as 08-07-2025 4:00pm EST
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Upcoming Earnings Alert:
Get ready for potential market movements as Smith & Nephew SNATS Inc. SNN prepares to release earnings report on 12 Aug 2025.
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 13.2B | IPO Year: | 1999 |
| Target Price: | $27.50 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.56 | EPS Growth: | 59.91 |
| 52 Week Low/High: | $23.69 - $36.56 | Next Earning Date: | 08-12-2025 |
| Revenue: | $5,944,000,000 | Revenue Growth: | 5.35% |
| Revenue Growth (this year): | 7.44% | Revenue Growth (next year): | 5.37% |
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Calciphylaxis Market Forecast Report 2025-2034 | Rising Incidence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) Fueling Demand and Growth
GlobeNewswire
a month ago
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
Zacks
a month ago
SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System
Zacks
a month ago
SNN vs. GEHC: Which Stock Is the Better Value Option?
Zacks
a month ago
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?
GlobeNewswire
a month ago
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
GlobeNewswire
2 months ago
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
Zacks
2 months ago
Smith+Nephew Stock May Gain From Strategic Deal With Standard Health
Compare SNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.